Annual Accounts Receivable
$41.73 M
+$3.76 M+9.91%
December 1, 2024
Summary
- As of February 24, 2025, ADPT annual accounts receivable is $41.73 million, with the most recent change of +$3.76 million (+9.91%) on December 1, 2024.
- During the last 3 years, ADPT annual accounts receivable has risen by +$24.32 million (+139.71%).
- ADPT annual accounts receivable is now at all-time high.
Performance
ADPT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$41.73 M
+$917.00 K+2.25%
December 1, 2024
Summary
- As of February 24, 2025, ADPT quarterly accounts receivable is $41.73 million, with the most recent change of +$917.00 thousand (+2.25%) on December 1, 2024.
- Over the past year, ADPT quarterly accounts receivable has increased by +$917.00 thousand (+2.25%).
- ADPT quarterly accounts receivable is now -0.69% below its all-time high of $42.02 million, reached on March 31, 2024.
Performance
ADPT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ADPT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.9% | +2.3% |
| 3 y3 years | +139.7% | +76.0% |
| 5 y5 years | +229.2% | +76.0% |
ADPT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +139.7% | -0.7% | +139.7% |
| 5 y | 5-year | at high | +315.4% | -0.7% | +427.3% |
| alltime | all time | at high | +768.1% | -0.7% | +926.3% |
Adaptive Biotechnologies Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $41.73 M(+9.9%) | $41.73 M(+2.2%) |
| Sep 2024 | - | $40.81 M(+14.6%) |
| Jun 2024 | - | $35.61 M(-15.3%) |
| Mar 2024 | - | $42.02 M(+10.7%) |
| Dec 2023 | $37.97 M(-5.2%) | $37.97 M(+21.7%) |
| Sep 2023 | - | $31.21 M(-1.1%) |
| Jun 2023 | - | $31.55 M(+1.9%) |
| Mar 2023 | - | $30.97 M(-22.7%) |
| Dec 2022 | $40.06 M(+130.1%) | $40.06 M(+50.9%) |
| Sep 2022 | - | $26.55 M(+12.0%) |
| Jun 2022 | - | $23.71 M(+5.3%) |
| Mar 2022 | - | $22.52 M(+29.3%) |
| Dec 2021 | $17.41 M | $17.41 M(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $17.12 M(+20.8%) |
| Jun 2021 | - | $14.17 M(-28.2%) |
| Mar 2021 | - | $19.75 M(+96.6%) |
| Dec 2020 | $10.05 M(-20.7%) | $10.05 M(-15.3%) |
| Sep 2020 | - | $11.86 M(+49.8%) |
| Jun 2020 | - | $7.91 M(-15.6%) |
| Mar 2020 | - | $9.38 M(-26.0%) |
| Dec 2019 | $12.68 M(+163.7%) | $12.68 M(+36.9%) |
| Sep 2019 | - | $9.26 M(+27.6%) |
| Jun 2019 | - | $7.25 M(+78.4%) |
| Mar 2019 | - | $4.07 M(-15.4%) |
| Dec 2018 | $4.81 M(-13.9%) | $4.81 M |
| Dec 2017 | $5.58 M | - |
FAQ
- What is Adaptive Biotechnologies annual accounts receivable?
- What is the all time high annual accounts receivable for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual accounts receivable year-on-year change?
- What is Adaptive Biotechnologies quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly accounts receivable year-on-year change?
What is Adaptive Biotechnologies annual accounts receivable?
The current annual accounts receivable of ADPT is $41.73 M
What is the all time high annual accounts receivable for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual accounts receivable is $41.73 M
What is Adaptive Biotechnologies annual accounts receivable year-on-year change?
Over the past year, ADPT annual accounts receivable has changed by +$3.76 M (+9.91%)
What is Adaptive Biotechnologies quarterly accounts receivable?
The current quarterly accounts receivable of ADPT is $41.73 M
What is the all time high quarterly accounts receivable for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly accounts receivable is $42.02 M
What is Adaptive Biotechnologies quarterly accounts receivable year-on-year change?
Over the past year, ADPT quarterly accounts receivable has changed by +$917.00 K (+2.25%)